PTO Director Opposes Review With High Court Of Patent- Term Adjustment Challenge
WASHINGTON, D.C. — An appellate court correctly rejected a pharmaceutical company’s challenge to the way the U.S. Patent and Trademark Office (PTO) calculated patent-term adjustments for two of its patents on...To view the full article, register now.
Already a subscriber? Click here to view full article